Certain Artificial Eyelash Extension Systems, Products, and Components Thereof; Commission Determination Not To Review an Initial Determination Granting Complainant's Motion for Leave To Amend the Complaint and Notice of Investigation, 9535 [2021-03059]

Download as PDF Federal Register / Vol. 86, No. 29 / Tuesday, February 16, 2021 / Notices must offer you the opportunity to appeal the decision in accordance with the agency’s procedures. If the agency has received and acted upon or will act upon a SAVE verification and you do not believe the response is correct, you may make an appointment for an inperson interview at a local USCIS office. Detailed information on how to make corrections or update your immigration record, make an appointment, or submit a written request to correct records under the Freedom of Information Act can be found on the SAVE website at www.uscis.gov/save. Tracy L. Renaud, Senior Official Performing the Duties of the Director, U.S. Citizenship and Immigration Services. [FR Doc. 2021–03149 Filed 2–12–21; 8:45 am] BILLING CODE P INTERNATIONAL TRADE COMMISSION [Investigation No. 337–TA–1226] Certain Artificial Eyelash Extension Systems, Products, and Components Thereof; Commission Determination Not To Review an Initial Determination Granting Complainant’s Motion for Leave To Amend the Complaint and Notice of Investigation U.S. International Trade Commission. ACTION: Notice. AGENCY: Notice is hereby given that the U.S. International Trade Commission has determined not to review an initial determination (‘‘ID’’) (Order No. 10) of the presiding administrative law judge (‘‘ALJ’’) granting the complainant’s motion for leave to amend the complaint and notice of investigation. FOR FURTHER INFORMATION CONTACT: Lynde Herzbach, Office of the General Counsel, U.S. International Trade Commission, 500 E Street SW, Washington, DC 20436, telephone (202) 205–3228. Copies of non-confidential documents filed in connection with this investigation may be viewed on the Commission’s electronic docket (EDIS) at https://edis.usitc.gov. For help accessing EDIS, please email EDIS3Help@usitc.gov. General information concerning the Commission may also be obtained by accessing its internet server at https://www.usitc.gov. Hearing-impaired persons are advised that information on this matter can be obtained by contacting the Commission’s TDD terminal on (202) 205–1810. khammond on DSKJM1Z7X2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 17:04 Feb 12, 2021 Jkt 253001 On October 28, 2020, the Commission instituted this investigation under section 337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337 (‘‘section 337’’), based on a complaint filed by Lashify, Inc. of Glendale, California (‘‘Complainant’’). See 85 FR 68366–67. The complaint, as supplemented, alleges a violation of section 337 based upon the importation into the United States, sale for importation, or sale after importation into the United States of certain artificial eyelash extension systems, products, and components thereof by reason of infringement of certain claims of U.S. Patent Nos. 10,660,388 and 10,721,984 and U.S. Design Patent Nos. D877,416 and D867,664. The complaint also alleges the existence of a domestic industry. The notice of investigation names nine respondents, including CVS Health Corporation of Woonsocket, Rhode Island and Ulta Beauty, Inc. of Bolingbrook, Illinois. See id. The Office of Unfair Import Investigations is also a party to the investigation. See id. On January 8, 2021, Complainant filed a motion seeking leave to amend the complaint and notice of investigation to substitute: (1) CVS Pharmacy, Inc. in place of CVS Health Corporation and (2) Ulta Salon, Cosmetics & Fragrance, Inc. in place of Ulta Beauty, Inc. No responses to the motion were filed. On January 22, 2021, the ALJ issued the subject ID (Order No. 10) granting Complainant’s motion for leave to amend the complaint and notice of investigation to reflect the substitutions. Order No. 10 (Jan. 22, 2021). The subject ID finds that Complainant’s motion is supported by good cause pursuant to Commission Rule 210.14(b) (19 CFR 210.14(b)) and that there is no prejudice if the motion is granted. No party petitioned for review of the subject ID. The Commission has determined not to review the subject ID. CVS Pharmacy, Inc. and Ulta Salon, Cosmetics & Fragrance, Inc. are named as respondents in this investigation; and CVS Health Corporation and Ulta Beauty, Inc. are terminated from the investigation. The Commission vote for this determination took place on February 10, 2021. The authority for the Commission’s determination is contained in section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and in Part 210 of the Commission’s Rules of Practice and Procedure (19 CFR part 210). SUPPLEMENTARY INFORMATION: By order of the Commission. PO 00000 Frm 00059 Fmt 4703 Sfmt 4703 9535 Issued: February 10, 2021. Lisa Barton, Secretary to the Commission. [FR Doc. 2021–03059 Filed 2–12–21; 8:45 am] BILLING CODE 7020–02–P INTERNATIONAL TRADE COMMISSION [Investigation No. 731–TA–1059 (Third Review)] Hand Trucks and Certain Parts Thereof From China Determination On the basis of the record 1 developed in the subject five-year review, the United States International Trade Commission (‘‘Commission’’) determines, pursuant to the Tariff Act of 1930 (‘‘the Act’’), that revocation of the antidumping duty order on hand trucks and certain parts thereof from China would be likely to lead to continuation or recurrence of material injury to an industry in the United States within a reasonably foreseeable time. Background The Commission instituted this review on July 1, 2020 (85 FR 39584) and determined on October 5, 2020 that it would conduct an expedited review (86 FR 2001, January 11, 2021). The Commission made this determination pursuant to section 751(c) of the Act (19 U.S.C. 1675(c)). It completed and filed its determination in this review on February 9, 2021. The views of the Commission are contained in USITC Publication 5159 (February 2021), entitled Hand Trucks and Certain Parts Thereof from China: Investigation No. 731–TA–1059 (Third Review). By order of the Commission. Issued: February 9, 2021. Lisa Barton, Secretary to the Commission. [FR Doc. 2021–02975 Filed 2–12–21; 8:45 am] BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–784] Importer of Controlled Substances Application: S and B Pharma, Inc. Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: 1 The record is defined in § 207.2(f) of the Commission’s Rules of Practice and Procedure (19 CFR 207.2(f)). E:\FR\FM\16FEN1.SGM 16FEN1

Agencies

[Federal Register Volume 86, Number 29 (Tuesday, February 16, 2021)]
[Notices]
[Page 9535]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-03059]


=======================================================================
-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigation No. 337-TA-1226]


Certain Artificial Eyelash Extension Systems, Products, and 
Components Thereof; Commission Determination Not To Review an Initial 
Determination Granting Complainant's Motion for Leave To Amend the 
Complaint and Notice of Investigation

AGENCY: U.S. International Trade Commission.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the U.S. International Trade 
Commission has determined not to review an initial determination 
(``ID'') (Order No. 10) of the presiding administrative law judge 
(``ALJ'') granting the complainant's motion for leave to amend the 
complaint and notice of investigation.

FOR FURTHER INFORMATION CONTACT: Lynde Herzbach, Office of the General 
Counsel, U.S. International Trade Commission, 500 E Street SW, 
Washington, DC 20436, telephone (202) 205-3228. Copies of non-
confidential documents filed in connection with this investigation may 
be viewed on the Commission's electronic docket (EDIS) at https://edis.usitc.gov. For help accessing EDIS, please email 
[email protected]. General information concerning the Commission may 
also be obtained by accessing its internet server at https://www.usitc.gov. Hearing-impaired persons are advised that information on 
this matter can be obtained by contacting the Commission's TDD terminal 
on (202) 205-1810.

SUPPLEMENTARY INFORMATION: On October 28, 2020, the Commission 
instituted this investigation under section 337 of the Tariff Act of 
1930, as amended, 19 U.S.C. 1337 (``section 337''), based on a 
complaint filed by Lashify, Inc. of Glendale, California 
(``Complainant''). See 85 FR 68366-67. The complaint, as supplemented, 
alleges a violation of section 337 based upon the importation into the 
United States, sale for importation, or sale after importation into the 
United States of certain artificial eyelash extension systems, 
products, and components thereof by reason of infringement of certain 
claims of U.S. Patent Nos. 10,660,388 and 10,721,984 and U.S. Design 
Patent Nos. D877,416 and D867,664. The complaint also alleges the 
existence of a domestic industry. The notice of investigation names 
nine respondents, including CVS Health Corporation of Woonsocket, Rhode 
Island and Ulta Beauty, Inc. of Bolingbrook, Illinois. See id. The 
Office of Unfair Import Investigations is also a party to the 
investigation. See id.
    On January 8, 2021, Complainant filed a motion seeking leave to 
amend the complaint and notice of investigation to substitute: (1) CVS 
Pharmacy, Inc. in place of CVS Health Corporation and (2) Ulta Salon, 
Cosmetics & Fragrance, Inc. in place of Ulta Beauty, Inc. No responses 
to the motion were filed.
    On January 22, 2021, the ALJ issued the subject ID (Order No. 10) 
granting Complainant's motion for leave to amend the complaint and 
notice of investigation to reflect the substitutions. Order No. 10 
(Jan. 22, 2021). The subject ID finds that Complainant's motion is 
supported by good cause pursuant to Commission Rule 210.14(b) (19 CFR 
210.14(b)) and that there is no prejudice if the motion is granted. No 
party petitioned for review of the subject ID.
    The Commission has determined not to review the subject ID. CVS 
Pharmacy, Inc. and Ulta Salon, Cosmetics & Fragrance, Inc. are named as 
respondents in this investigation; and CVS Health Corporation and Ulta 
Beauty, Inc. are terminated from the investigation.
    The Commission vote for this determination took place on February 
10, 2021.
    The authority for the Commission's determination is contained in 
section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and 
in Part 210 of the Commission's Rules of Practice and Procedure (19 CFR 
part 210).

    By order of the Commission.
    Issued: February 10, 2021.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2021-03059 Filed 2-12-21; 8:45 am]
BILLING CODE 7020-02-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.